This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment

Sponsored by Entac Medical Inc.

About this trial

Last updated 3 years ago

Study ID

Entac-PrevisEA-001

Status

Unknown

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18 to 90 Years
All Sexes

Not accepting

Healthy Volunteers

Trial Timing

Ended 2 years ago

What is this trial about?

PrevisEA is a noninvasive, disposable device that uses audio spectral analysis of sounds produced by the gastrointestinal tract to predict gastrointestinal impairment (GII). GII is most commonly associated with postoperative ileus (POI), but could be the result of other causes, such as early postoperative bowel obstruction. GII is defined as failure of successful early oral re-feeding in a subject undergoing major abdominal surgery. For subjects who are allowed to resume a diet during the first 24 hours after surgery, a failure to successfully orally re-feed a subject is defined as presentation with emesis, requiring a reversal of diet, or the placement of a nasogastric tube on first postoperative day or later. The device is considered non-significant risk (NSR). The device does not inform medical decisions in this study. Researchers will be blinded to results of the device during this study.

What are the participation requirements?

Inclusion Criteria

1. Age ≥ 18 and ≤ 90 years

2. Patient undergoing elective intestinal resection surgery including open, laparoscopic, robotic, or hand-assist technique for:

1. Segmental ileocolic resection with or without diversion
2. Segmental colon resection with or without diversion
3. Segmental coloproctectomy with or without diversion
4. Low anterior resection with or without diversion
5. Abdominoperineal resection
6. Total abdominal colectomy with or without diversion
7. Proctocolectomy with or without end ileostomy or diversion
8. Closure of end colostomy (Hartmann's reversal)

Exclusion Criteria

1. Allergies to any of the device components (i.e., adhesive)

2. Inability to have prototype device applied to their abdominal wall due to disease conditions or surgical alterations(e.g., fistulas, stomas, drains, etc.)

3. Patients undergoing:

1. Small bowel resection without colonic resection
2. Transanal proctectomy without transabdominal approach
3. Perineal proctosigmoidectomy
4. Closure of loop colostomy or ileostomy

4. Patients with preoperative evidence of an anastomotic leak, deep wound infection, organ space infection, or urinary tract infection